Search research articles
Contact Us
Filters
Showing results (71-80 of 78) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 78 results.
The Journal of Pharmacology and Experimental Therapeutics
|
October 1, 1990
Antinociceptive action of McN-5195 in rodents: a structurally novel (indolizine) analgesic with a nonopioid mechanism of action
J L Vaught, J R Carson, R J Carmosin, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
January 1, 1991
Structurally novel antihypertensive compound, McN-5691, is a calcium channel blocker in vascular smooth muscle
S F Flaim, M M Gleason, A Hedberg, et al.
Epilepsia
|
March 1, 1994
Topiramate: preclinical evaluation of structurally novel anticonvulsant
R P Shank, J F Gardocki, J L Vaught, et al.
Journal of Medicinal Chemistry
|
January 6, 1995
Potential anxiolytic agents. Pyrido[1,2-a]benzimidazoles: a new structural class of ligands for the benzodiazepine binding site on GABA-A receptors
B E Maryanoff, W Ho, D F McComsey, et al.
Bioorganic & Medicinal Chemistry
|
July 15, 2000
2,3-Dihydro-dithiin and -dithiepine-1,1,4,4-tetroxides: small molecule non-peptide antagonists of the human galanin hGAL-1 receptor
M K Scott, T M Ross, D H Lee, et al.
Journal of Medicinal Chemistry
|
April 15, 1994
A new arylpiperazine antipsychotic with high D2/D3/5-HT1A/alpha 1A-adrenergic affinity and a low potential for extrapyramidal effects
A B Reitz, D J Bennett, P S Blum, et al.
Journal of Medicinal Chemistry
|
May 1, 1989
Activity of aromatic substituted phenylpiperazines lacking affinity for dopamine binding sites in a preclinical test of antipsychotic efficacy
G E Martin, R J Elgin, J R Mathiasen, et al.
Journal of Medicinal Chemistry
|
June 17, 1998
Orally active benzamide antipsychotic agents with affinity for dopamine D2, serotonin 5-HT1A, and adrenergic alpha1 receptors
A B Reitz, E W Baxter, E E Codd, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 78) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 78 results.
The Journal of Pharmacology and Experimental Therapeutics
|
October 1, 1990
Antinociceptive action of McN-5195 in rodents: a structurally novel (indolizine) analgesic with a nonopioid mechanism of action
J L Vaught, J R Carson, R J Carmosin, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
January 1, 1991
Structurally novel antihypertensive compound, McN-5691, is a calcium channel blocker in vascular smooth muscle
S F Flaim, M M Gleason, A Hedberg, et al.
Epilepsia
|
March 1, 1994
Topiramate: preclinical evaluation of structurally novel anticonvulsant
R P Shank, J F Gardocki, J L Vaught, et al.
Journal of Medicinal Chemistry
|
January 6, 1995
Potential anxiolytic agents. Pyrido[1,2-a]benzimidazoles: a new structural class of ligands for the benzodiazepine binding site on GABA-A receptors
B E Maryanoff, W Ho, D F McComsey, et al.
Bioorganic & Medicinal Chemistry
|
July 15, 2000
2,3-Dihydro-dithiin and -dithiepine-1,1,4,4-tetroxides: small molecule non-peptide antagonists of the human galanin hGAL-1 receptor
M K Scott, T M Ross, D H Lee, et al.
Journal of Medicinal Chemistry
|
April 15, 1994
A new arylpiperazine antipsychotic with high D2/D3/5-HT1A/alpha 1A-adrenergic affinity and a low potential for extrapyramidal effects
A B Reitz, D J Bennett, P S Blum, et al.
Journal of Medicinal Chemistry
|
May 1, 1989
Activity of aromatic substituted phenylpiperazines lacking affinity for dopamine binding sites in a preclinical test of antipsychotic efficacy
G E Martin, R J Elgin, J R Mathiasen, et al.
Journal of Medicinal Chemistry
|
June 17, 1998
Orally active benzamide antipsychotic agents with affinity for dopamine D2, serotonin 5-HT1A, and adrenergic alpha1 receptors
A B Reitz, E W Baxter, E E Codd, et al.
Page
of 8